1 Min Read
Feb 6 (Reuters) - BriaCell Therapeutics Corp -
* Submitted CMC amendment which includes details of extensive testing performed on BriaVax, vaccine for advanced breast cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.